Evidence map›Paper›PMID 38831631›Full record

ArticleEpilepsia open2024

Pulsatile corticoid therapy reduces interictal epileptic activity burden in children with genetic drug-resistant epilepsy.

Katharina Schiller, John Thomas, Tamir Avigdor, Daniel Mansilla, Aline Kortas, Gabriele Unterholzner, Markus Rauchenzauner, Birgit Frauscher

Abstract read
In one paragraph

Article in Epilepsia open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Rethinking Corticosteroid Therapy in Pediatric Neurology.Journal of inflammation research · 2026
    Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Katharina SchillerAnalytical Neurophysiology Lab, Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0002-2163-3857
John ThomasAnalytical Neurophysiology Lab, Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0003-0144-3746
Tamir AvigdorAnalytical Neurophysiology Lab, Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0003-1283-7978
Daniel MansillaAnalytical Neurophysiology Lab, Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, Montreal, Quebec, Canada.
Aline KortasDepartment of Neurology, Children's Hospital Kaufbeuren, Kaufbeuren, Bavaria, Germany.
Gabriele UnterholznerDepartment of Neurology, Children's Hospital Kaufbeuren, Kaufbeuren, Bavaria, Germany.
Markus RauchenzaunerDepartment of Neurology, Children's Hospital Kaufbeuren, Kaufbeuren, Bavaria, Germany.
Birgit FrauscherAnalytical Neurophysiology Lab, Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0001-6064-1529

Funding

CIHR PJT-175056
6 · The paper itself

Abstract

objectiveCorticosteroids and adrenocorticotropic hormone (ACTH) are the therapy of choice to treat infantile spasms. However, systematic studies about their use in other types of childhood epilepsies remain rare and ACTH can have serious side effects. This study compares the interictal epileptic activity (IEA) burden (% of electroencephalography (EEG) time with IEDs) in children with genetic drug-resistant epilepsy before and after a standardized treatment with pulsatile corticoid therapy (PCT).

methodsChildren with drug-resistant epilepsy underwent a standardized protocol for PCT with cycles of high-dose dexamethasone (20 mg/m

resultsIn the cohort of 24 children (10 female, 6.2 ± 3.4 years), IEA burden was lower in the EEG after PCT compared to the baseline (baseline: 5.4% [0.7-97.3] vs. after PCT: 1.5% [0-96.9], p = 0.001, d = -0.41). Sleep physiology expressed by sleep spindles improved after PCT with enhanced fast spindle rates (0.8/min [0-2.2] vs. 1.5/min [0.2-3.4], p = 0.045, d = 0.36). Seizure frequency was decreased in 17 of the 24 patients (70.8%) with one patient achieving seizure freedom. The majority of patients improved in quality of life (79.2%), and sleep (81.3%). No serious adverse effects were documented. SIGNIFICANCE: This study systematically assessed the effect of PCT in children with genetic / suspected genetic drug-resistant epilepsy. PCT was found to not only reduce the IEA burden but also increase sleep spindle rates, which are important for cognitive functioning. PLAIN LANGUAGE SUMMARY: In this study, children with a form of epilepsy, which is resistant against antiseizure medication, received a systematic treatment with corticosteroids over multiple cycles in the hospital. It was found that not only the epileptic activity was reduced but also the sleep of the patients was improved after the treatment. These findings could provide the basis for extending the use of corticosteroids in children with epilepsy.

Indexed as

DexamethasoneDrug Resistant EpilepsyElectroencephalographyAdrenal Cortex HormonesAnticonvulsantsChildChild, PreschoolFemaleHumansMaleTreatment OutcomeAdrenal Cortex HormonesAnticonvulsantsDexamethasonechildrendexamethasoneEEGepilepsyinterictal activitysleep spindle

Identifiers

PMID38831631
PMCPMC11296103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.